Javelin Pharmaceuticals

Javelin Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the research, development, and commercialization of products.

Launch date

1998

Employees

Market cap

Net debt

Enterprise valuation

$95m (Public information from Dec 2009)

Cambridge Massachusetts (HQ)

Get premium to view all results

Date	Investors	Amount	Round
Nov 2005	investor	$0.0	round
Jul 2006	investor	$0.0	round
Dec 2009	Myriad Genetics	$95.0m Valuation: $95.0m	Acquisition
Total Funding		000k

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Javelin Pharmaceuticals